Simultaneous production of fatty acids and sugars from tropical microalgae
Innovative process using tropical microalgae to produce long-chain fatty acids and glucans under extreme conditions, utilizing industrial wastewater and CO2. Promises enhanced biochemical yields while reducing environmental impact.
Overview
This solution leverages tropical microalgae's natural resilience to extreme conditions, such as intense sunlight and industrial pollutants, to efficiently produce valuable biochemicals. By cultivating selected strains that thrive in wastewater and CO2-rich environments, this process simultaneously generates long-chain saturated fatty acids (LC-SFA) and glucans. This approach not only enhances the yield of these base chemicals but also minimizes environmental impact by utilizing industrial by-products as growth inputs.
Technical specifications
Key features of this process include:
- Resilient microalgae strains: These extremophilic strains are capable of thriving in tropical environments with high sunlight and temperatures.
- Dual chemical production: Simultaneous generation of LC-SFA and glucans, which are essential for various industrial applications.
- Sustainable inputs: Utilizes industrial wastewater and CO2, reducing waste and emissions while providing necessary nutrients for microalgae growth.
- Pilot scale validation: Future plans include scaling up to a pilot open pond system and experimenting with mixed-species cultures to enhance growth and productivity.
Technology readiness level
Currently at TRL 4, the technology has been validated in small-scale environments. The next steps involve scaling to a pilot level and conducting economic feasibility studies to progress towards TRL 5. This will involve modeling growth and productivity, as well as cost analyses to ensure competitive viability against conventional methods.
About Lipidware Sdn Bhd
Lipidware Sdn Bhd is a Malaysian biotechnology company founded in 2017 as a university startup from Universiti Putra Malaysia (UPM) through the Putra Science Park InnoHub Programme. The company specializes in translating academic research into commercialized skincare solutions, most notably its REMDII brand. Developed by researchers in biotechnology and biochemistry, the company’s core innovation involves a patented bioactive delivery system that utilizes full-spectrum tocotrienols—a form of Vitamin E—to provide targeted anti-inflammatory and barrier-repair properties for sensitive and eczema-prone skin. This research-driven approach includes rigorous independent testing and ethics-approved human clinical trials to ensure safety and efficacy as a steroid-free alternative for individuals of all ages.
Beyond product development, Lipidware plays a significant role in community education and support through the Malaysia Eczema Support Community (MESC), which provides resources and guidance for patients and caregivers. The company’s efforts bridge the gap between clinical science and practical health management, addressing skin conditions such as atopic dermatitis, psoriasis, and actinic keratosis. Through its commitment to real science, Lipidware has earned numerous national and international accolades for innovation and commercialization, successfully moving university-backed breakthroughs from the laboratory to pharmacy shelves to improve patient quality of life.
delivered to your inbox.